Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of normal saline (an isotonic sodium chloride solution) and triamcinolone, a synthetic glucocorticoid corticosteroid. The mixture is typically prepared by diluting triamcinolone with normal saline to achieve the desired concentration for injection. Triamcinolone acts as an anti-inflammatory and immunosuppressive agent by binding to glucocorticoid receptors, modulating gene expression, and suppressing the production of pro-inflammatory mediators. Normal saline serves as a diluent to adjust the steroid concentration for safe administration, particularly in intralesional or intramuscular injections. This combination is used in various dermatological and musculoskeletal conditions such as seborrheic dermatitis, keloids, hypertrophic scars, arthritis, tendonitis, and other inflammatory disorders[1][2]. The dilution allows for tailored dosing based on lesion size or clinical indication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on normal saline + triamcinolone.